Definitive Healthcare Corp. · Healthcare · Health Information Services
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$1.28
−$0.12 (−8.86%) 4:00 PM ET
After hours$1.32
+$0.04 (+3.45%) 4:30 PM ET
Prev closePrevC$1.40
OpenOpen$1.29
Day highHigh$1.29
Day lowLow$1.15
VolumeVol585,315
Avg volAvgVol344,557
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$132.23M
P/E ratio
-1.01
FY Revenue
$241.52M
EPS
-1.26
Gross Margin
75.88%
Sector
Healthcare
AI report sections
MIXED
DH
Definitive Healthcare Corp.
Definitive Healthcare’s share price is down roughly 36–40% over the past 6–12 months and trades near the lower end of its 52-week range, although recent technical signals point to short-term momentum stabilizing with multiple bullish indicator crossovers. Fundamentally, the company combines high gross margins and positive free cash flow with large GAAP operating and net losses and slightly negative revenue growth. Short interest metrics show elevated days-to-cover and a high short-volume ratio, while the news backdrop has recently been dominated by investigations following a substantial goodwill impairment and guidance reduction.
Definitive Healthcare announced that it granted inducement awards, including 364,432 time-based restricted stock units, to its new SVP of Growth and Sales Operations, Jeff Moyer, as part of his employment agreement.
DHDefinitive Healthcareinducement awardsrestricted stock units
Sentiment note
The article neutrally reports on Definitive Healthcare's inducement grants to a new executive, which is a common practice for public companies.
NegativeBenzinga• Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
Law Offices of Howard G. Smith is investigating Definitive Healthcare Corp. (DH) for possible violations of federal securities laws after the company disclosed a $363.6 million goodwill impairment and reduced its fiscal year 2024 guidance, causing a significant drop in its stock price.
The company disclosed a significant goodwill impairment and reduced its fiscal year guidance, which led to a substantial drop in its stock price, indicating potential issues that could negatively impact investors.
NegativeBenzinga• Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
The Law Offices of Frank R. Cruz announced an investigation into Definitive Healthcare Corp. after the company disclosed a $363.6 million goodwill impairment and reduced its 2024 fiscal year guidance, causing a 32.1% drop in its stock price.
DHDefinitive Healthcare Corp.goodwill impairmentstock price drop
Sentiment note
The company disclosed a significant goodwill impairment and reduced its financial guidance, which led to a substantial drop in its stock price, indicating negative news for investors.
NeutralGlobeNewswire Inc.• Researchandmarkets.Com
United Kingdom Healthcare Market Report 2024: The Role of Private Payers and Independent Sector Providers, Alongside the Public Sector, in the Funding and Delivery of UK Health and Care Services
The report provides a comprehensive overview of the UK independent healthcare and social care sectors, including data on market value, capacity, trends, leading players, funding sources, and key issues. It highlights the role of private payers and independent sector providers, alongside the public sector, in the funding and delivery of UK health and care services.
The report covers the Private Acute Healthcare sector as part of the broader healthcare landscape, but does not provide any specific insights or sentiment towards this segment.
FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award
Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data sharing
Definitive Healthcare to Present at the Stifel 2024 Cross Sector Insight Conference
FRAMINGHAM, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the Stifel 2024 Cross Sector Insight Conference.
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
FRAMINGHAM, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder, Interim CEO, and Executive Chairman, Jason Krantz, will present at the J.P. Morgan Global Technology, Media and Communications Conference.
DHCalendar of Events
UnknownZacks Investment Research• Zacks Equity Research
DH or PRVA: Which Is the Better Value Stock Right Now?
DH vs. PRVA: Which Stock Is the Better Value Option?
DHPRVA
UnknownZacks Investment Research• Zacks Equity Research
Bears are Losing Control Over Definitive Healthcare (DH), Here's Why It's a 'Buy' Now
Definitive Healthcare (DH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
DH
UnknownZacks Investment Research• Nalak Das
5 Medical Info Systems Stocks to Buy for Stable Returns
We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.
LUNGHIMSBFLYDH
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
